Investor presentation for earnings conference call with analysts/ institutional investors scheduled for 5 August 2026

AI summary - Merger effective July 1, 2026, forming Aster DM Quality Care Limited with zero operational friction - Q1FY27 proforma revenue grew 20% YoY to INR 2,597 Cr; EBITDA up 30% YoY to INR 576 Cr with 22.2% margin - Patient volume increased 13% YoY; ARPP IP rose 10% driven by high-end tertiary procedures - Kasargod hospital breakeven within nine months; 159 beds commissioned at Aster Whitefield in Apr 2026 - Strong regional performance: Kerala, Karnataka, Maharashtra, Andhra & Telangana showing growth - Quality Care segment revenue up 19% YoY; EBITDA margin improved to 23.2% - Medical Value Travel grew 62-72% YoY, led by Maldives, GCC, Africa, and MENA markets - Expansion plans include adding 4,179 beds by FY30, total capacity reaching 15,077 beds - Clinical excellence highlighted by multiple pioneering surgeries and accreditations - Management focused on synergy realization targeting 10-15% EBITDA uplift